Kai, Y., Amatya, V. J., Kushitani, K., Kambara, T., Suzuki, R., Fujii, Y., . . . Takeshima, Y. (2021). Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung. Transl Lung Cancer Res.
Citación estilo ChicagoKai, Yuichiro, et al. "Glypican-1 Is a Novel Immunohistochemical Marker to Differentiate Poorly Differentiated Squamous Cell Carcinoma From Solid Predominant Adenocarcinoma of the Lung." Transl Lung Cancer Res 2021.
Cita MLAKai, Yuichiro, et al. "Glypican-1 Is a Novel Immunohistochemical Marker to Differentiate Poorly Differentiated Squamous Cell Carcinoma From Solid Predominant Adenocarcinoma of the Lung." Transl Lung Cancer Res 2021.